# An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate

> **NCT03577470** · — · COMPLETED · sponsor: **Janssen-Cilag S.p.A.** · enrollment: 246 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV)

## Interventions

- **DRUG:** D/C/F/TAF Fixed-Dose Combination (FDC)

## Key facts

- **NCT ID:** NCT03577470
- **Lead sponsor:** Janssen-Cilag S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-13
- **Primary completion:** 2020-09-28
- **Final completion:** 2020-09-28
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03577470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03577470, "An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03577470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*